🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementHypoglycemia risk with concomitant sulfonylurea use — my results so far Page 3

Hypoglycemia risk with concomitant sulfonylurea use — my results so far

mike.trainer_LA Thu, Apr 4, 2024 at 5:38 PM 34 replies 2,155 viewsPage 3 of 7
FranDenver
Member
267
1,123
Oct 2024
Denver, CO
Apr 4, 2024 at 9:53 PM#11
InsuranceTom said:
Hypoglycemia risk with concomitant is not that straightforward in my experience

This is exactly right. InsuranceTom articulated what I have been trying to explain to my friends for months. The Hypoglycemia risk with aspect is what made the difference for me.

Last edited: Apr 5, 2024 at 3:53 AM
17 3Dr.RenalNash, LipidDoc_ATL, BariatricNurseD and 14 others
Reply Quote Save Share Report
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Apr 4, 2024 at 10:10 PM#12

Reading this thread on Hypoglycemia risk with hits close to home. Dad of 2 checking in — I started at 297 lbs and felt like I would tried everything.

13 months on tirz and I am a different person. Not just the 72 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Hypoglycemia risk — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Apr 5, 2024 at 1:10 AM
17 22JessicaH_TX, KevinCompounds, TirzTom and 14 others
Reply Quote Save Share Report
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Apr 4, 2024 at 10:27 PM#13

VendorMark — that is really helpful context on Hypoglycemia risk with. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

22 9carl_compliance, DanielChem_CHI, marco_milano and 19 others
Reply Quote Save Share Report
Dr.NutriCornell
Senior Member
1,345
6,234
Mar 2024
Ithaca, NY
Apr 4, 2024 at 10:44 PM#14

To answer stefan_berlin's question specifically:

From a clinical standpoint, Hypoglycemia risk with is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

30 23JenMemphis, pat_auckland, Dr.GastroMayo and 27 others
Reply Quote Save Share Report
JakeSmashed95
Member
412
1,890
Aug 2024
Arkansas
Online
Apr 4, 2024 at 11:01 PM#15

Bookmarked 📌 The Hypoglycemia risk info in this thread is essential. Coming back to this for sure.

15 2tammy_FL, Dr.LipidDallas, alex_tucson and 12 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register